Differentiation of Mouse Neural Crest Cells Into Corneal Endothelial-Like Cells by Inhibiting TGF-β Signaling Pathway

Purpose: Corneal endothelial dysfunction causes irreversible blindness, yet treatment remains limited by donor tissue shortage. This study aimed to generate induced corneal endothelial-like cells (iCEnCs) from mouse neural crest cells (NCCs) via TGF-β inhibition. Methods: NCCs were isolated from Wnt1-Cre; Rosa26-LSL-tdTomato mice by fluorescence-activated cell sorting. NCCs were treated with the TGF-β inhibitor SB431542 to induce differentiation into iCEnCs. The CEnC-like phenotype was characterized by immunofluorescence, functional assays, and bulk RNA sequencing in comparison with mouse NCCs and CEnCs. Therapeutic efficacy was assessed by transplanting iCEnCs into a rabbit model of corneal endothelial dysfunction. Results: SB431542 efficiently directed NCCs to differentiate into polygonal, cobblestone-like iCEnCs expressing CEnC markers (ZO-1, Na⁺/K⁺-ATPase, AQP1, Laminin). Approximately 35% of iCEnCs at P5 remained Ki67-positive, indicating maintained proliferative activity. These cells also achieved near-complete wound closure within 24 hours. Transcriptomic profiling showed that iCEnCs resembled primary corneal endothelial cells (pCEnCs) and were distinct from NCCs. After transplantation, iCEnCs formed a confluent endothelial-like monolayer, normalized central corneal thickness by day 21, and restored corneal transparency by day 35. Conclusions: TGF-β signaling inhibition enables efficient differentiation of mouse NCCs into corneal endothelial-like cells with functional characteristics, maintained proliferative activity, and in vivo therapeutic efficacy. This strategy provides a potential scalable, donor-independent cell source for the development of cell-based therapies for corneal endothelial diseases.

Authors

Institutions

Publication Details

Journal
Investigative Ophthalmology & Visual Science
Published
2026-11-16
DOI
https://doi.org/10.1167/iovs.67.13.23
Primary Topic
Corneal Surgery and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Differentiation of Mouse Neural Crest Cells Into Corneal Endothelial-Like Cells by Inhibiting TGF-β Signaling Pathway

Yuedan Fan, Kai Huang, Jiahang Li, Di Cao et al.
1 links
Investigative Ophthalmology & Visual Science
Corneal Surgery and Treatments
article

Differentiation of Mouse Neural Crest Cells Into Corneal Endothelial-Like Cells by Inhibiting TGF-β Signaling Pathway

Yuedan Fan, Kai Huang, Jiahang Li, Di Cao, Jingjing Yu, Yunfen Li, Nanxin Wu, Shaohui Pan, Miyao Zhu, Liya Ma, Wencan Wu
article en

Abstract

Purpose: Corneal endothelial dysfunction causes irreversible blindness, yet treatment remains limited by donor tissue shortage. This study aimed to generate induced corneal endothelial-like cells (iCEnCs) from mouse neural crest cells (NCCs) via TGF-β inhibition. Methods: NCCs were isolated from Wnt1-Cre; Rosa26-LSL-tdTomato mice by fluorescence-activated cell sorting. NCCs were treated with the TGF-β inhibitor SB431542 to induce differentiation into iCEnCs. The CEnC-like phenotype was characterized by immunofluorescence, functional assays, and bulk RNA sequencing in comparison with mouse NCCs and CEnCs. Therapeutic efficacy was assessed by transplanting iCEnCs into a rabbit model of corneal endothelial dysfunction. Results: SB431542 efficiently directed NCCs to differentiate into polygonal, cobblestone-like iCEnCs expressing CEnC markers (ZO-1, Na⁺/K⁺-ATPase, AQP1, Laminin). Approximately 35% of iCEnCs at P5 remained Ki67-positive, indicating maintained proliferative activity. These cells also achieved near-complete wound closure within 24 hours. Transcriptomic profiling showed that iCEnCs resembled primary corneal endothelial cells (pCEnCs) and were distinct from NCCs. After transplantation, iCEnCs formed a confluent endothelial-like monolayer, normalized central corneal thickness by day 21, and restored corneal transparency by day 35. Conclusions: TGF-β signaling inhibition enables efficient differentiation of mouse NCCs into corneal endothelial-like cells with functional characteristics, maintained proliferative activity, and in vivo therapeutic efficacy. This strategy provides a potential scalable, donor-independent cell source for the development of cell-based therapies for corneal endothelial diseases.

Investigative Ophthalmology & Visual ScienceVol. 67(13)
Wenzhou Medical University (CN), Affiliated Eye Hospital of Wenzhou Medical College (CN), Hangzhou Institute of Medicine, Chinese Academy of Sciences (CN)
Good health and well-being
Corneal Surgery and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon